(1)
Pharmacoeconomic Aspects of Warfarin and New Oral Anticoagulants Use As Prevention of Thromboembolic Complications in Patients With Atrial Fibrillation. UJC 2020, 27 (4), 45-53. https://doi.org/10.31928/1608-635X-2020.4.4553.